Search Results - "Sasase, Noriko"

Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy by El‐Shamy, Ahmed, Nagano‐Fujii, Motoko, Sasase, Noriko, Imoto, Susumu, Kim, Soo‐Ryang, Hotta, Hak

“…A substantial proportion of hepatitis C virus (HCV)‐1b–infected patients still do not respond to interferon‐based therapy. This study aims to explore a…”
Get full text

Drug-induced sarcoidosis-like reaction three months after BNT162b2 mRNA COVID-19 vaccination: A case report and review of literature by Kim, Soo Ryang, Kim, Soo Ki, Fujii, Takako, Kobayashi, Hisato, Okuda, Toyokazu, Hayakumo, Takanobu, Nakai, Atsushi, Fujii, Yumi, Suzuki, Ryuji, Sasase, Noriko, Otani, Aya, Koma, Yu-Ichiro, Sasaki, Motoko, Kumabe, Tsutomu, Nakashima, Osamu

“…A 70-year-old man with hepatitis C virus-related recurrent hepatocellular carcinoma was admitted for further diagnosis of a 1 cm iso-hyperechoic nodule in…”
Get full text

Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma by Taniguchi, Miyuki, Kim, Soo-Ryang, Imoto, Susumu, Ikawa, Hirotsugu, Ando, Kenji, Mita, Keiji, Fuki, Shuichi, Sasase, Noriko, Matsuoka, Toshiyuki, Kudo, Masatoshi, Hayashi, Yoshitake

“…AIM： To evaluate long-term follow-up of minimum-sized hepatocellular carcinoma （HCC） treated with percutaneous ethanol injection （PEI）. METHODS： PEI was…”
Get full text

Prediction of Efficient Virological Response to Pegylated Interferon/Ribavirin Combination Therapy by NS5A Sequences of Hepatitis C Virus and Anti-NS5A Antibodies in Pre-Treatment Sera by El-Shamy, Ahmed, Sasayama, Mikiko, Nagano-Fujii, Motoko, Sasase, Noriko, Imoto, Susumu, Kim, Soo Ryang, Hotta, Hak

“…A considerable number of patients infected with Hepatitis C virus subtype 1b (HCV‐1b) do not respond to pegylated interferon/ribavirin combination therapy. In…”
Get full text

Polymorphisms of hepatitis C virus non-structural protein 5A and core protein and clinical outcome of pegylated-interferon/ribavirin combination therapy by El-Shamy, Ahmed, Kim, Soo-Ryang, Ide, Yoshi-Hiro, Sasase, Noriko, Imoto, Susumu, Deng, Lin, Shoji, Ikuo, Hotta, Hak

“…Hepatitis C virus (HCV genome) polymorphisms are thought to influence the outcome of pegylated-interferon/ribavirin (PEG-IFN/RBV) therapy. This study aimed to…”
Get more information

Focal Nodular Hyperplasia-like Lesion with Venous Washout in Alcoholic Liver Cirrhosis by Kim, Soo Ryang, Imoto, Susumu, Ikawa, Hirotsugu, Ando, Kenji, Mita, Keiji, Shimizu, Kenji, Taniguchi, Miyuki, Sasase, Noriko, Matsuoka, Toshiyuki, Kudo, Masatoshi, Kawada, Norifumi, Hayashi, Yoshitake

“…A case of 22 mm hypervascular nodule in segment two of the liver but without hepatitis B or C virus infection in a 32-year-old Japanese woman with a history of…”
Get full text

Acute Pancreatitis Associated with Pegylated Interferon and Ribavirin Treatment of Chronic Hepatitis C, Genotype 1b with High Viral Load by Ando, Kenji, Kim, Soo Ryang, Imoto, Susumu, Nakajima, Taisuke, Mita, Keiji, Fukuda, Katsumi, Taniguchi, Miyuki, Sasase, Noriko, Muramatsu, Akira, Matsuoka, Toshiyuki, Kudo, Masatoshi, Hayashi, Yoshitake

“…Acute pancreatitis, an uncommon side effect of pegylated interferon α (PEG-IFN α) and ribavirin (RBV) combination therapy, has rarely been reported in the…”
Get full text

Prediction of efficacy of interferon treatment of chronic hepatitis C and occurrence of HCC after interferon treatment by a new classification by Kim, Ke Ih, Sasase, Noriko, Taniguchi, Miyuki, Mita, Keiji, Kim, Soo Ryang, Tanaka, Kazuhiko, Hayashi, Yoshitake

“…One hundred and twenty-one chronic hepatitis C patients were administered interferon (IFN) and divided into two groups: 31 complete responders (CR) with…”
Get more information

Outcome and early viral dynamics with viral mutation in PEG-IFN/RBV therapy for chronic hepatitis in patients with high viral loads of serum HCV RNA genotype 1b by Sasase, Noriko, Kim, Soo Ryang, Kudo, Masatoshi, Kim, Ke Ih, Taniguchi, Miyuki, Imoto, Susumu, Mita, Keiji, Hayashi, Yoshitake, Shoji, Ikuo, El-Shamy, Ahmed, Hotta, Hak

“…We investigated whether sustained virological response (SVR) and non-SVR by chronic hepatitis C patients to pegylated interferon plus ribavirin (PEG-IFN/RBV)…”
Get more information

Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C with high viral load of serum hepatitis C virus RNA, genotype 1b, discontinued on attaining sustained virological response at week 16 after onset of acute pancreatitis by Kim, Soo Ryang, Imoto, Susumu, Mita, Keiji, Taniguchi, Miyuki, Sasase, Noriko, Muramatsu, Akira, Kudo, Masatoshi, Kitai, Satoshi, El-Shamy, Ahmed, Hotta, Hak, Hayashi, Yoshitake

“…Recent clinical trials have shown that pegylated interferon-alpha (PEG-IFN-alpha) in combination with ribavirin (RBV) improves the rate of sustained…”
Get more information

Double-Filtration Plasmapheresis plus Interferon-β for HCV-1b Patients with Non-Sustained Virological Response to Previous Combination Therapy by Kim, Soo Ryang, Saito, Jun, Imoto, Susumu, Komaki, Takamitsu, Nagata, Yoshiaki, Kim, Ke Ih, Sasase, Noriko, Kimura, Noriyo, Sasatani, Kanako, Konishi, Erika, Hasegawa, Yutaka, Fujinami, Aya, Ohta, Mitsuhiro, El-Shamy, Ahmed, Tanaka, Yasuhito, Sugano, Masahiko, Sakashita, Masanori, Nakamura, Akira, Tsuchida, Shinobu, Makino, Tetsuya, Kawada, Tetsumi, Nakajima, Takatoshi, Morikawa, Teruhisa, Muramatsu, Akira, Kasugai, Hiroshi, Hotta, Hak, Kudo, Masatoshi

“…Double-filtration plasmapheresis (DFPP) together with interferon (IFN) administration produces a substantial reduction in the viral load during the early…”
Get more information

Well-differentiated hepatocellular carcinoma smaller than 15 mm in diameter totally eradicated with percutaneous ethanol injection instead of radiofrequency ablation by Kim, Soo Ryang, Imoto, Susumu, Nakajima, Taisuke, Ando, Kenji, Mita, Keiji, Taniguchi, Miyuki, Sasase, Noriko, Matsuoka, Toshiyuki, Kudo, Masatoshi, Hayashi, Yoshitake

“…We describe three cases of well-differentiated hepatocellular carcinoma (HCC) smaller than 15 mm in diameter completely eradicated with percutaneous ethanol…”
Get full text

Double-filtration plasmapheresis plus IFN for HCV-1b patients with non-sustained virological response to previous combination therapy: early viral dynamics by Kim, Soo Ryang, Imoto, Susumu, Kudo, Masatoshi, Mita, Keiji, Taniguchi, Miyuki, Kim, Ke Ih, Sasase, Noriko, Shoji, Ikuo, Nagano-Fujii, Motoko, El-Shamy, Ahmed, Hotta, Hak, Nagai, Tomoyuki, Nagata, Yoshiaki, Hayashi, Yoshitake

“…Double-filtration plasmapheresis (DFPP) was approved in Japan in April 2008 for the retreatment of chronic hepatitis C patients with genotype 1b and high viral…”
Get more information

Blood cell, liver function, and response changes by PEG-interferon-α2b plus ribavirin with polaprezinc therapy in patients with chronic hepatitis C by Kim, Ke Ih, Kim, Soo Ryang, Sasase, Noriko, Akimoto, Yoko, Shikata, Mao, Ohtani, Aya, Hirooka, Teruko, Tanaka, Kazuhiko

“…Purpose Zinc has been reported to ameliorate hematologic side effects and improve liver function. In addition to its various effects, zinc supplementation in…”
Get full text

Usefulness of a new immunoradiometric assay of HCV core antigen to predict virological response during PEG-IFN/RBV combination therapy for chronic hepatitis with high viral load of serum HCV RNA genotype 1b by Sasase, Noriko, Kim, Soo Ryang, Kim, Ke Ih, Taniguchi, Miyuki, Imoto, Susumu, Mita, Keiji, Hotta, Hak, Shouji, Ikuo, El-Shamy, Ahmed, Kawada, Norifumi, Kudo, Masatoshi, Hayashi, Yoshitake

“…We investigated the clinical usefulness of a new immunoradiometric (IRM) assay of hepatitis C virus (HCV) core antigen in predicting virological response…”
Get more information

Blood cell, liver function, and response changes by PEG-interferon-alpha2b plus ribavirin with polaprezinc therapy in patients with chronic hepatitis C by Kim, Ke Ih, Kim, Soo Ryang, Sasase, Noriko, Akimoto, Yoko, Shikata, Mao, Ohtani, Aya, Hirooka, Teruko, Tanaka, Kazuhiko

“…Zinc has been reported to ameliorate hematologic side effects and improve liver function. In addition to its various effects, zinc supplementation in chronic…”
Get full text

Blood cell, liver function, and response changes by PEG-interferon-[alpha]2b plus ribavirin with polaprezinc therapy in patients with chronic hepatitis C by Kim, Ke Ih, Kim, Soo Ryang, Sasase, Noriko, Akimoto, Yoko, Shikata, Mao, Ohtani, Aya, Hirooka, Teruko, Tanaka, Kazuhiko

“…Zinc has been reported to ameliorate hematologic side effects and improve liver function. In addition to its various effects, zinc supplementation in chronic…”
Get full text

Well-differentiated HCC manifesting hyperattenuation on CT during arterial portography by Kim, Soo Ryang, Kim, Ke Ih, Maekawa, Yoko, Imoto, Susumu, Ninomiya, Toshiaki, Mita, Keiji, Ando, Kenji, Fukuda, Katsumi, Fuki, Syuichi, Kudo, Masatoshi, Matsuoka, Toshiyuki, Sasase, Noriko, Taniguchi, Miyuki, Hayashi, Yoshitake

“…A rare case of well-differentiated minute hepatocellular carcinoma (HCC) with hepatitis C virus-related cirrhosis, with unusual radiologic features, is…”
Get more information

Primary sclerosing cholangitis and hepatitis C virus infection by Kim, Soo Ryang, Imoto, Susumu, Taniguchi, Miyuki, Kim, Ke Ih, Sasase, Noriko, Matsuoka, Toshiyuki, Maekawa, Yoko, Ninomiya, Toshiaki, Ando, Kenji, Mita, Keiji, Fuki, Shuichi, Koterazawa, Toshihiro, Fukuda, Katsumi, Kudo, Masatoshi, Sakamoto, Hiroki, Hayashi, Yoshitake

“…Two cases of primary sclerosing cholangitis with hepatic C virus infection in a 62-year-old man and a 60-year-old woman are presented. The infection in the man…”
Get more information

Acute Pancreatitis Associated with Pegylated Interferon and Ribavirin Treatment of Chronic Hepatitis C, Genotype 1b with High Viral Load by Ando, Kenji, Kim, Soo Ryang, Imoto, Susumu, Nakajima, Taisuke, Mita, Keiji, Fukuda, Katsumi, Taniguchi, Miyuki, Sasase, Noriko, Muramatsu, Akira, Matsuoka, Toshiyuki, Kudo, Masatoshi, Hayashi, Yoshitake

Get full text